Skip to main content
AA-Xylazine, 20 mg/ml oplossing voor injectie voor honden en katten
  • Ksilazīna hidrohlorīds
  • Valid
Authorised in these countries:
  • Netherlands

Product identification

Medicine name:
AA-Xylazine, 20 mg/ml oplossing voor injectie voor honden en katten
Active substance and strength:
  • Ksilazīna hidrohlorīds
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Authorisation number:
  • REG NL 113340
Product identification number:
  • 9bff90fd-6ef3-44f9-94b4-1049a2e3f6bc
Permanent identification number:
  • 600000067830

Product details

Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat

Availability

Package description:
Manufacturing sites for batch release:
  • A.A.-Vet Diergeneesmiddelen N.V.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
This information is not available for this product.
Date of authorisation status change:
Authorisation country:
  • Netherlands
Responsible authority:
  • Medicines Evaluation Board
Marketing authorisation holder:
  • A.A.-Vet Diergeneesmiddelen N.V.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."